These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 21365978)

  • 1. Off by a factor of eight.
    Eldred EB
    J Miss State Med Assoc; 2010 Aug; 51(8):211-3. PubMed ID: 21365978
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?
    Anolik J
    J Rheumatol; 2011 Apr; 38(4):587-9. PubMed ID: 21459953
    [No Abstract]   [Full Text] [Related]  

  • 3. Lupus, "rhupus" and "sjrupus".
    Prabhakaran S; Handler RP
    J Rheumatol; 2011 Feb; 38(2):393. PubMed ID: 21285180
    [No Abstract]   [Full Text] [Related]  

  • 4. [Connective tissue diseases].
    Lorenz HM
    Dtsch Med Wochenschr; 2012 Mar; 137(13):661-3. PubMed ID: 22434176
    [No Abstract]   [Full Text] [Related]  

  • 5. Rituximab as early therapy for pulmonary haemorrhage in systemic lupus erythematosus.
    Narshi CB; Haider S; Ford CM; Isenberg DA; Giles IP
    Rheumatology (Oxford); 2010 Feb; 49(2):392-4. PubMed ID: 19926673
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus.
    Catapano F; Chaudhry AN; Jones RB; Smith KG; Jayne DW
    Nephrol Dial Transplant; 2010 Nov; 25(11):3586-92. PubMed ID: 20466686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of warm-type haemolytic anaemia with bortezomib in a rituximab-failed systemic lupus erythematosus patient.
    Wang Y; Zhou W; Zhang Z
    Rheumatology (Oxford); 2015 Jan; 54(1):194-5. PubMed ID: 25288787
    [No Abstract]   [Full Text] [Related]  

  • 8. Controversies in rheumatism and autoimmunity.
    Doria A; Putterman C; Sarzi-Puttini P; Szekanecz Z; Shoenfeld Y
    Autoimmun Rev; 2012 Jun; 11(8):555-7. PubMed ID: 22056979
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term improvement of lipid profile in patients with refractory systemic lupus erythematosus treated with B-cell depletion therapy: a retrospective observational study.
    Pego-Reigosa JM; Lu TY; Fontanillo MF; del Campo-Pérez V; Rahman A; Isenberg DA
    Rheumatology (Oxford); 2010 Apr; 49(4):691-6. PubMed ID: 20047982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of incapacitating acute cutaneous lupus erythematosus in a patient with systemic lupus erythematosus by B cell-depletive therapy.
    Kok MR; Vos K; Bos JD; Tak PP
    J Clin Rheumatol; 2010 Oct; 16(7):345. PubMed ID: 20859218
    [No Abstract]   [Full Text] [Related]  

  • 11. Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus.
    Faria RM; Isenberg DA
    Lupus; 2010 Sep; 19(10):1256-7. PubMed ID: 20534646
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric systemic lupus erythematosus in Thammasat University Hospital.
    Pusongchai T; Jungthirapanich J; Khositseth S
    J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S283-93. PubMed ID: 21294427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin.
    Conti F; Perricone C; Ceccarelli F; Valesini G
    Autoimmun Rev; 2010 Sep; 9(11):716-20. PubMed ID: 20667484
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral mucosal involvement in bullous lupus.
    Anyanwu CO; Ang CC; Werth VP
    Arthritis Rheum; 2013 Oct; 65(10):2622. PubMed ID: 23780804
    [No Abstract]   [Full Text] [Related]  

  • 15. Small muscle myositis in a patient with systemic lupus erythematosus successfully treated with rituximab.
    Hui M; Andres M; Latief K; Courtney P
    Lupus; 2011 Oct; 20(12):1340-1. PubMed ID: 21768178
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of rituximab in a patient with lupus nephritis despite low levels of CD19.
    Bacconnier L; Combe B; Canaud B; Morel J
    Rheumatology (Oxford); 2010 Dec; 49(12):2452-3. PubMed ID: 20591832
    [No Abstract]   [Full Text] [Related]  

  • 17. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT; Houghton K; Bond M; Senger C; Tucker LB
    J Rheumatol; 2010 Aug; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract]   [Full Text] [Related]  

  • 18. Impending cardiac tamponade as the initial presentation of thymoma in a systemic lupus erythematosus patient.
    Jang SJ; Wu YC; Chuang WY; Chung CM; Luo SF; Chu PH
    Lupus; 2010 Mar; 19(3):337-40. PubMed ID: 20015914
    [No Abstract]   [Full Text] [Related]  

  • 19. [Factor VII deficiency].
    Kändler H; Brendel B; Grotkopf P
    Padiatr Grenzgeb; 1990; 29(4):285-9. PubMed ID: 2216523
    [No Abstract]   [Full Text] [Related]  

  • 20. Childhood hermolytic uremic syndrome associated with systemic lupus erythematosus.
    Wu CY; Su YT; Wang JS; Chiou YH
    Lupus; 2007; 16(12):1006-10. PubMed ID: 18042599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.